Trial intelligence / Profile preview

Lidocaine SPGB vs Amitriptyline for Transformed Migraine

NCT02090998Phase 4Terminated

Sponsor
Rutgers University
Start
May 2014
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lidocaine 10% oropharyngeal spray in chronic migraine, sponsored by Rutgers University. Started May 2014; status: terminated.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

chronic migraine

Beyond the preview

Go deeper on NCT02090998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02090998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call